Bloomberg Law, November 25, 2024: Dr. Marty Makary has been named by Donald Trump to lead the FDA. The Johns Hopkins surgeon has been an outspoken critic of FDA’s relationships with industry and his appointment could shake up the status quo. NCHR and other experts are optimistic that Dr. Makary will encourage the agency to reduce conflicts of interest and hold industry to a higher standard for FDA approval of medical products and food safety.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
A documentary about menopause has ‘misinformation’ and shouldn’t be used to educate docs, critics say
STAT News, November 21, 2024: We joined other experts in criticizing the Federation of State Medical Boards (FSMB) for their documentary on menopause, which includes several inaccurate claims that hormone therapy has health benefits (such as preventing dementia and heart disease) that are not supported by research.
Read More »What Trump’s election win could mean for AI, climate and health
Nature, November 8, 2024: Nature magazine news article on the impact of Trump election includes views regarding health programs. NCHR asks if RFK Jr. stated plans to “reduce corporate greed” will be implemented, given the close ties between the first Trump Administration and the pharmaceutical industry.
Read More »Michelle Tarver faces challenges as new CDRH leader. But patient groups, industry are optimistic.
MedTech Dive, October 31, 2024: Article quotes industry officials and NCHR and other patient and consumer advocates about new CDRH director Michelle Tarver and hopes for greater respect for patients, consumers, and researchers during user fee negotiations and FDA decision-making regarding the safety and effectiveness standards for medical devices.
Read More »F.D.A. names a new chief of medical devices
New York Times, Oct 22, 2024: Michelle Tarver is the new director of CDRH, FDA medical device center, promoted from within the agency. We are hopeful that she will move CDRH to focus more on ensuring safe and effective medical devices, reversing the bias of former director Jeff Shuren. But given her expertise, why has the agency failed to warn Lasik patients as promised?
Read More »